Should we be using polyhexamethylene biguanide to treat Acanthamoeba keratitis?
Kumar
B
B
Crawford
G J
GJ
D015823:Acanthamoeba Keratitis / Q000188:drug therapy* / Q000209:etiology; D000287:Administration, Topical; D001645:Biguanides / Q000008:administration & dosage / Q000627:therapeutic use*; D003261:Contact Lenses / Q000009:adverse effects; D003315:Cornea / Q000187:drug effects / Q000469:parasitology / Q000473:pathology; D004202:Disinfectants / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009883:Ophthalmic Solutions
D001645:Biguanides; D004202:Disinfectants; D009883:Ophthalmic Solutions; C031233:polihexanide